Current through P.L. 171-2024
Section 16-42-19-30 - Investigation of suspected legend drugs; records(a) Sections 16 and 20 of this chapter do not apply to the actions of a: (1) person who is employed or retained as an investigator by a pharmaceutical manufacturer described in subdivision (3);(3) pharmaceutical manufacturer that is approved by the federal Food and Drug Administration; performed in an investigation of a pharmaceutical manufacturer's legend drug that is suspected of being counterfeited, adulterated, or misbranded.
(b) A drug sample collected during an investigation described in subsection (a) may only be used for testing or a civil or criminal action. A drug sample collected during an investigation may not be resold or provided for human consumption.(c) A pharmaceutical manufacturer that collects drug samples during an investigation described in subsection (a) shall:(1) maintain records of the drug samples; and(2) make these records available, at a reasonable time, to law enforcement agencies or the agencies' representatives in the enforcement of this chapter.Added by P.L. 48-2015, SEC. 4, eff. 7/1/2015.